| Title: | The Cognitive Footprint of Medication Use |
| Journal: | Brain and Behavior |
| Published: | 19 Jan 2025 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/39829148/ |
| DOI: | https://doi.org/10.1002/brb3.70200 |
Publication 14898
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
INTRODUCTION: The cognitive side-effects of medication are common, but often overlooked in practice, and not routinely considered in interventional trials or post-market surveillance. The cognitive footprint of a medication seeks to quantify the impact of its cognitive effects based on magnitude, duration, and interaction with other factors, evaluated across the exposed population.</p>
METHODS: Bayesian multivariable regression analysis of retrospective population-based cross-sectional cohorts.</p>
RESULTS: We replicate positive and negative cognitive effects of commonly used medications in UK Biobank, and extend observed associations to two additional cohorts, the EPIC Norfolk, and the Caerphilly Prospective Cohort. We quantify the resultant cumulative impact at the population level given known patterns of prescribing and compare it with exemplar common diseases.</p>
CONCLUSION: The cognitive side-effects of commonly used drugs may have significant impact at the population level. Consideration should be given to a routine structured assessment of cognition in interventional trials and post-market surveillance.</p>
13 Keywords
- Adult
- Aged
- Bayes Theorem
- Cognition
- Cross-Sectional Studies
- Drug-Related Side Effects and Adverse Reactions
- Female
- Humans
- Male
- Middle Aged
- Prospective Studies
- Retrospective Studies
- United Kingdom
5 Authors
- Marta Suárez Pinilla
- Charlotte R. Stoner
- Martin Knapp
- Parashkev Nachev
- Martin Rossor
Enabling scientific discoveries that improve human health